Polyamyna

St. John's, Newfoundland and Labrador, Canada, A1A 1B3

https://www.polyamyna.ca/

Company profile

Polyamyna company profile

Polyamyna helps to develop next-generation antimicrobial technologies to prevent infections caused by deadly pathogens, especially ESKAPE bacteria. Their products includes advanced antimicrobial technologies and disinfectant technology. Their customer can contact them through online.

Business identity

Website: https://www.polyamyna.ca/
Operating status: Active
Company type: For Profit
Employee range: 11-50 employees
Revenue range: $0-$1M
Founded: 2017-01-01

LinkedIn X

Headquarters

Headquarters: St. John's, Newfoundland and Labrador, Canada
Postal code: A1A 1B3
Country code: CA
Continent: North America

Capital profile

Funding and company signals

Funding rounds: 4
Total equity funding: $1.4M
Last funding: Series Unknown / $353,921 / 2023-09-05
Last equity funding: Series Unknown / $353,921
Investors: 4
Lead investors: 1
Founders: 2
Articles: 1

Categories and groups

Biotechnology Life Science Nanotechnology Biotechnology Science and Engineering

Founders and investors

Founders

Kishan GorityalaRamesh Kumar Mani

Lead investors

Sustainable Development Technology Canada

Investors

GenesisGovernment of Newfoundland and LabradorNational Research Council of Canada Industrial Research Assistance ProgramSustainable Development Technology Canada